J u m p t o c o n t e n t
M a i n m e n u
M a i n m e n u
N a v i g a t i o n
● M a i n p a g e
● C o n t e n t s
● C u r r e n t e v e n t s
● R a n d o m a r t i c l e
● A b o u t W i k i p e d i a
● C o n t a c t u s
● D o n a t e
C o n t r i b u t e
● H e l p
● L e a r n t o e d i t
● C o m m u n i t y p o r t a l
● R e c e n t c h a n g e s
● U p l o a d f i l e
S e a r c h
Search
A p p e a r a n c e
● C r e a t e a c c o u n t
● L o g i n
P e r s o n a l t o o l s
● C r e a t e a c c o u n t
● L o g i n
P a g e s f o r l o g g e d o u t e d i t o r s l e a r n m o r e
● C o n t r i b u t i o n s
● T a l k
( T o p )
1
B i o g r a p h y
2
C O V I D - 1 9 v a c c i n e r e s e a r c h
3
P e r s o n a l l i f e
4
H o n o u r s a n d a w a r d s
5
S e e a l s o
6
R e f e r e n c e s
7
E x t e r n a l l i n k s
T o g g l e t h e t a b l e o f c o n t e n t s
C h e n W e i ( m e d i c a l s c i e n t i s t )
6 l a n g u a g e s
● C a t a l à
● E s p a ñ o l
● G a l e g o
● 日 本 語
● У к р а ї н с ь к а
● 中 文
E d i t l i n k s
● A r t i c l e
● T a l k
E n g l i s h
● R e a d
● E d i t
● V i e w h i s t o r y
T o o l s
T o o l s
A c t i o n s
● R e a d
● E d i t
● V i e w h i s t o r y
G e n e r a l
● W h a t l i n k s h e r e
● R e l a t e d c h a n g e s
● U p l o a d f i l e
● S p e c i a l p a g e s
● P e r m a n e n t l i n k
● P a g e i n f o r m a t i o n
● C i t e t h i s p a g e
● G e t s h o r t e n e d U R L
● D o w n l o a d Q R c o d e
● W i k i d a t a i t e m
P r i n t / e x p o r t
● D o w n l o a d a s P D F
● P r i n t a b l e v e r s i o n
A p p e a r a n c e
F r o m W i k i p e d i a , t h e f r e e e n c y c l o p e d i a
Chen Wei (Chinese : 陈薇 ; born February 1966) is a Chinese epidemiologist and virologist specializing in biodefense , and is currently working as a researcher and doctoral advisor at the Academy of Military Medical Sciences , and is an Academician of the Chinese Academy of Engineering (CAE). In September 2021, The Globe and Mail reported that Chen is also a major general in China's People's Liberation Army .[3]
Biography [ edit ]
Chen was born in Lanxi County , Jinhua , Zhejiang, in 1966.[2] She received her bachelor's degree in chemical engineering from the Zhejiang University in 1988.[1] [4] She obtained a master's degree at Tsinghua University in 1991.[2] She attended the Academy of Military Medical Sciences where she obtained her doctor's degree in 1998.[2] She became a faculty member of the academy upon graduation.
In 2013, Chen became a delegate of the People's Liberation Army to the National People's Congress .[1]
On 10 July 2015, she was awarded the military rank of major general (shaojiang ) by Central Military Commission chairman Xi Jinping .[5]
She was a delegate to the 12th National People's Congress .[6] In January 2018, she became a member of the 13th National Committee of the Chinese People's Political Consultative Conference .[7] In November 2019, She was elected as an academician of the Chinese Academy of Engineering .[8]
On May 30, 2021, she was elected vice president of the China Association for Science and Technology .[9]
COVID-19 vaccine research [ edit ]
In 2020, Chen led a joint team of the Institute of Biotechnology, the Academy of Military Medical Sciences , and CanSino Biologics to develop Convidecia . The development team registered a Phase 1 trial in March 2020 and a Phase 2 trial in April 2020.[10] [11] It conducted its Phase III trials in Argentina ,[12] Chile ,[13] Mexico ,[14] Pakistan ,[15] Russia ,[16] and Saudi Arabia [17] with 40,000 participants.
In February 2021, global data from Phase III trials and 101 COVID cases showed the vaccine had a 65.7% efficacy in preventing moderate symptoms of COVID-19 , and 91% efficacy in preventing severe disease.[18]
Convidecia is approved for use by some countries in Asia,[19] [20] [21] Europe,[22] [23] and Latin America.[24] [25] [26]
Personal life [ edit ]
Chen is married to her husband who is a native of Shandong province and they have a son.[27]
Honours and awards [ edit ]
See also [ edit ]
References [ edit ]
^ Fife, Robert; Chase, Steven (16 September 2021). "Chinese Major-General worked with fired scientist at Canada's top infectious disease lab" . The Globe and Mail . Archived from the original on 16 September 2021. Retrieved 17 September 2021 .
^ a b Lin, Lin (12 January 2012). "The Eighth Chinese Young Women in Science Awards" . All-China Women's Federation . Archived from the original on 16 April 2020. Retrieved 16 April 2020 .
^ Tsinghua University (16 July 2015). 解放军总后勤部女博导陈薇晋升少将(图) . ifeng.com (in Chinese). Retrieved 23 January 2020 .
^ 第十二届全国人民代表大会代表名单 . Sohu (in Chinese). 27 February 2013. Retrieved 23 January 2020 .
^ 中国人民政治协商会议第十三届全国委员会常务委员名单 . cppcc.gov.cn (in Chinese). 14 March 2018. Retrieved 23 January 2020 .
^ 中国工程院2019年当选院士名单 [List of Members of the Chinese Academy of Engineering in 2019]. CAE (in Chinese). 22 November 2019. Retrieved 15 January 2020 .
^ 陈薇新当选、潘建伟连任!金华好儿女双双当选中国科协副主席 . 163.com (in Chinese). 31 May 2021. Retrieved 1 June 2021 .
^ Xie, John (15 April 2020). "China Announces Phase 2 of Clinical Trials of COVID-19 Vaccine" . Voice of America . Retrieved 18 April 2020 .
^ "The Lancet: First human trial of COVID-19 vaccine finds it is safe and induces rapid immune response" . EurekAlert! . 22 May 2020. Retrieved 24 December 2020 .
^ "Comenzará en la Argentina un nuevo estudio de vacuna recombinante contra el SARS-CoV-2" . infobae (in European Spanish). 14 December 2020. Retrieved 15 December 2020 .
^ "Gob.cl - Article: Science Minister: "We Work With Maximum Rigor So That Science And Technology Benefit People'S Health" " . Government of Chile . Retrieved 21 November 2020 .
^ "Chinese Covid vaccine trials to be expanded to five more states" . Mexico News Daily . 10 November 2020. Retrieved 11 November 2020 .
^ "Phase III Trial of A COVID-19 Vaccine of Adenovirus Vector in Adults 18 Years Old and Above - Full Text View - ClinicalTrials.gov" . clinicaltrials.gov . Retrieved 21 October 2020 .
^ "Russia approves clinical trials for Chinese COVID-19 vaccine Ad5-Ncov: Ifax" . Reuters . 7 December 2020. Retrieved 7 December 2020 .
^ Eltahir N (9 August 2020). "CanSino to start Phase III trial of COVID-19 vaccine in Saudi" . Reuters . Retrieved 9 August 2020 .
^ "CanSinoBIO's COVID-19 vaccine 65.7% effective in global trials, Pakistan official says" . Reuters . 8 February 2021. Retrieved 8 February 2021 .
^ Liu, Roxanne (25 February 2021). "China approves two more domestic COVID-19 vaccines for public use" . Reuters . Retrieved 26 February 2021 .
^ "Pakistan purchases over 30 million COVID doses from China: sources" . ARY NEWS . 25 April 2021. Retrieved 26 April 2021 .
^ "Malaysia to receive CanSino vaccine this month | The Malaysian Insight" . www.themalaysianinsight.com . Retrieved 3 April 2021 .
^ Ashok, Rashmi (22 March 2021). "UPDATE 2-China's CanSino Biologics COVID-19 vaccine receives emergency use approval in Hungary" . Reuters . Retrieved 22 March 2021 .
^ "Membrii NITAG au venit cu recomandări privind utilizarea vaccinurilor împotriva COVID-19 în Republica Moldova" . Ministerul Sănătății, Muncii și Protecţiei Sociale . 3 March 2021. Retrieved 21 May 2021 .
^ " 'Our gratitude always': From China's CanSino, Mexico welcomes biggest vaccine shipment yet" . Reuters . 11 February 2021. Retrieved 11 February 2021 .
^ "Argentina issues emergency approval to China's single-dose Cansino COVID-19 vaccine" . Reuters . 11 June 2021. Retrieved 11 June 2021 .
^ "ISP Approves Emergency Use And Importation Of Cansino Vaccine To Fight COVID-19" . Institute of Public Health of Chile . Retrieved 8 April 2021 .
^ 苏容. "科学家陈薇:我相信爱情" . 中国妇女 . Archived from the original on 3 March 2020. Retrieved 3 March 2020 .
^ "Xi Jinping signs order to award 4 people for outstanding contribution in COVID-19 fight" . Xinhuanet . 11 August 2020. Retrieved 11 October 2020 .
External links [ edit ]
R e t r i e v e d f r o m " https://en.wikipedia.org/w/index.php?title=Chen_Wei_(medical_scientist)&oldid=1218003429 "
C a t e g o r i e s :
● 1 9 6 6 b i r t h s
● L i v i n g p e o p l e
● C h i n e s e e p i d e m i o l o g i s t s
● C h i n e s e v i r o l o g i s t s
● D e l e g a t e s t o t h e 1 2 t h N a t i o n a l P e o p l e ' s C o n g r e s s
● M e m b e r s o f t h e 1 3 t h C h i n e s e P e o p l e ' s P o l i t i c a l C o n s u l t a t i v e C o n f e r e n c e
● M e m b e r s o f t h e C h i n e s e A c a d e m y o f E n g i n e e r i n g
● P e o p l e f r o m L a n x i , Z h e j i a n g
● P e o p l e ' s L i b e r a t i o n A r m y g e n e r a l s f r o m Z h e j i a n g
● E d u c a t o r s f r o m J i n h u a
● S c i e n t i s t s f r o m J i n h u a
● A c a d e m i c s t a f f o f T s i n g h u a U n i v e r s i t y
● W o m e n e p i d e m i o l o g i s t s
● W o m e n v i r o l o g i s t s
● Z h e j i a n g U n i v e r s i t y a l u m n i
H i d d e n c a t e g o r i e s :
● C S 1 u s e s C h i n e s e - l a n g u a g e s c r i p t ( zh )
● C S 1 C h i n e s e - l a n g u a g e s o u r c e s ( zh )
● C S 1 E u r o p e a n S p a n i s h - l a n g u a g e s o u r c e s ( e s - e s )
● A r t i c l e s w i t h s h o r t d e s c r i p t i o n
● S h o r t d e s c r i p t i o n i s d i f f e r e n t f r o m W i k i d a t a
● U s e d m y d a t e s f r o m A p r i l 2 0 2 0
● A r t i c l e s w i t h h C a r d s
● A r t i c l e s c o n t a i n i n g C h i n e s e - l a n g u a g e t e x t
● A r t i c l e s c o n t a i n i n g s i m p l i f i e d C h i n e s e - l a n g u a g e t e x t
● T h i s p a g e w a s l a s t e d i t e d o n 9 A p r i l 2 0 2 4 , a t 0 5 : 0 6 ( U T C ) .
● T e x t i s a v a i l a b l e u n d e r t h e C r e a t i v e C o m m o n s A t t r i b u t i o n - S h a r e A l i k e L i c e n s e 4 . 0 ;
a d d i t i o n a l t e r m s m a y a p p l y . B y u s i n g t h i s s i t e , y o u a g r e e t o t h e T e r m s o f U s e a n d P r i v a c y P o l i c y . W i k i p e d i a ® i s a r e g i s t e r e d t r a d e m a r k o f t h e W i k i m e d i a F o u n d a t i o n , I n c . , a n o n - p r o f i t o r g a n i z a t i o n .
● P r i v a c y p o l i c y
● A b o u t W i k i p e d i a
● D i s c l a i m e r s
● C o n t a c t W i k i p e d i a
● C o d e o f C o n d u c t
● D e v e l o p e r s
● S t a t i s t i c s
● C o o k i e s t a t e m e n t
● M o b i l e v i e w